InfuSystem Holdings logo

InfuSystem HoldingsNYSE American: INFU

Profile

Sector:

Healthcare

Country:

United States

IPO:

27 December 2007

Next earnings report:

07 November 2024

Last dividends:

N/A

Next dividends:

N/A
$136.21 M
-64%vs. 3y high
48%vs. sector
480.45
-83%vs. 3y high
99%vs. sector
-68%vs. 3y high
65%vs. sector
-72%vs. 3y high
24%vs. sector

Price

pre-market | 24 min ago
$6.39$0.00(0.00%)

Dividend

No data over the past 3 years
$33.70 M$34.48 M
$33.70 M$717.00 K

Analysts recommendations

Institutional Ownership

INFU Latest News

InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
businesswire.com31 October 2024 Sentiment: NEUTRAL

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024.

The Future of Medical Devices: Two Strong Buys You Can't Miss
marketbeat.com10 October 2024 Sentiment: POSITIVE

The medical device market, a powerhouse sector, is projected to exceed $600 billion by 2025. This growth is fueled by a combination of factors, including an aging population, rising healthcare costs, and rapid technological advancements powered by advanced artificial intelligence (AI) and biotechnology.

InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
businesswire.com27 September 2024 Sentiment: NEUTRAL

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024.

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC
globenewswire.com11 September 2024 Sentiment: POSITIVE

FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara's joint venture partner InfuSystem Holdings, Inc., announced today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (“ChemoMouthpiece”).

InfuSystem Holdings, Inc. (INFU) Q2 2024 Earnings Call Transcript
seekingalpha.com10 August 2024 Sentiment: NEUTRAL

InfuSystem Holdings, Inc. (NYSE:INFU ) Q2 2024 Earnings Call Transcript August 8, 2024 9:00 AM ET Company Participants Joe Dorame - Investor Relations Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Matt Hewitt - Craig-Hallum Capital Group Jim Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings, Inc. Second Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode.

InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024
businesswire.com04 June 2024 Sentiment: POSITIVE

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Small Cap Conference on June 12, 2024.

InfuSystem Holdings: 2024 Will Be A Year Of Monetization
Seeking Alpha28 February 2024 Sentiment: POSITIVE

InfuSystem stock has not performed well compared to the S&P 500, but the company has made significant investments that are expected to pay off in 2024 and beyond. The company's struggles over the past two years were due to making investments that will be monetized in 2024 and beyond. INFU's biomed and wound care businesses are expected to drive growth in 2024, with opportunities for expansion and increased profitability.

InfuSystem Holdings Inc. (INFU) Q1 2023 Earnings Call Transcript
Seeking Alpha06 May 2023 Sentiment: POSITIVE

InfuSystem Holdings Inc. (NYSE:INFU ) Q1 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Joe Dorame - IR, Lytham Partners Richard DiIorio - CEO Barry Steele - CFO Carrie Lachance - President and Chief Operating Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Alexander Nowak - Craig-Hallum Capital Group James Sidoti - Sidoti & Company Operator Good day, and welcome to the InfuSystem Holdings Inc. First Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note that today's event is being recorded.

InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023
Business Wire05 May 2023 Sentiment: POSITIVE

ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Present at Sidoti Micro-Cap Virtual Conference on May 11, 2023.

InfuSystem: Disappointing 2022 Results Lead To Bargain Prices
Seeking Alpha10 April 2023 Sentiment: POSITIVE

INFU has produced impressive growth over the past six quarters, but let down investors during this timeframe because it fell short of its own guidance. In short, INFU's business plans simply took longer to come to fruition than the company expected, so the opportunity for massive growth still exists.

What type of business is InfuSystem Holdings?

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

What sector is InfuSystem Holdings in?

InfuSystem Holdings is in the Healthcare sector

What industry is InfuSystem Holdings in?

InfuSystem Holdings is in the Medical Instruments & Supplies industry

What country is InfuSystem Holdings from?

InfuSystem Holdings is headquartered in United States

When did InfuSystem Holdings go public?

InfuSystem Holdings initial public offering (IPO) was on 27 December 2007

What is InfuSystem Holdings website?

https://www.infusystem.com

Is InfuSystem Holdings in the S&P 500?

No, InfuSystem Holdings is not included in the S&P 500 index

Is InfuSystem Holdings in the NASDAQ 100?

No, InfuSystem Holdings is not included in the NASDAQ 100 index

Is InfuSystem Holdings in the Dow Jones?

No, InfuSystem Holdings is not included in the Dow Jones index

When was InfuSystem Holdings the previous earnings report?

No data

When does InfuSystem Holdings earnings report?

The next expected earnings date for InfuSystem Holdings is 07 November 2024